Get the Stockscreener App
6.64
2.00%
+0.13
After Hours:
6.60
-0.04
-0.60%
Relay Therapeutics Inc Stock (RLAY) Forecast
The Relay Therapeutics Inc (RLAY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.0304, representing a -39.30% decrease from the current price of $6.64. The highest analyst price target is $6.4852, and the lowest is $1.5755.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RLAY Price Target
Average 15.70
(+136.48% Upside)
Is Relay Therapeutics Inc (RLAY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.68 | Neutral |
| STOCH(9,6) | 19.54 | Buy |
| STOCHRSI(14) | 66.11 | Neutral |
| MACD(12,26) | -0.162 | Buy |
| ADX(14) | 28.85 | Buy |
| William %R | -83.13 | Buy |
| CCI(14) | -44.94 | Neutral |
Buy: 4
Sell: 0
Neutral: 3
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.5765
Buy
|
6.574
Buy
|
| MA20 |
6.519
Buy
|
6.6425
Sell
|
| MA50 |
7.1896
Sell
|
7.2574
Sell
|
| MA100 |
8.7471
Sell
|
8.065
Sell
|
| MA200 |
8.8523
Sell
|
9.4814
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, RLAY could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on RLAY, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 47.68 indicates that RLAY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.54 indicates that RLAY is oversold. This indicates that RLAY price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.11 indicates that RLAY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.85 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -44.94 indicates that RLAY is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RLAY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Relay Therapeutics Inc financial reports and earnings history, Relay Therapeutics Inc (RLAY) stock could reach $23.49 by 2030, $53.22 by 2040 and $32.77 by 2050. See the projected annual prices until 2050 of the Relay Therapeutics Inc stock below:
- Relay Therapeutics Inc (RLAY) is expected to reach an average price of $47.98 in 2035, with a high prediction of $48.25 and a low estimate of $49.95. This indicates an $622.63% rise from the last recorded price of $6.64.
- Relay Therapeutics Inc (RLAY) stock is projected to chart a bullish course in 2040, with an average price target of $51.91, representing an $681.71% surge from its current level. The forecast ranges from a conservative $52.85 to a sky-high $53.22.
- Our analysts predict Relay Therapeutics Inc (RLAY) to jump 632.41% by 2045, soaring from $49.03 to an average price of $48.63, potentially reaching $48.70. While $49.03 is the low estimate, the potential upside is significant.
- Relay Therapeutics Inc (RLAY) stock is expected to climb by 2050, reaching an average of $32.87, a $395.10% jump from its current level. However, a wide range of estimates exists, with high and low targets of $32.77 and $32.78, respectively, highlighting the market's uncertainty.
Relay Therapeutics Inc Stock (RLAY) Year by Year Forecast
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2024
Our forecast for RLAY stock price in 2024 now indicates an average price target of $15.78 with a high forecast of $31.27 and a low forecast of $0.2912. The average prediction reflects an increase of +137.68% from the last recorded price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.8552 | $1.5755 | $6.4852 | -41.94% |
| July, 2024 | $6.959 | $0.5125 | $14.12 | +4.80% |
| August, 2024 | $4.812 | $0.2912 | $10.12 | -27.53% |
| September, 2024 | $18.46 | $1.0827 | $21.74 | +178.09% |
| October, 2024 | $13.86 | $8.6187 | $23.23 | +108.72% |
| November, 2024 | $11.61 | $2.961 | $15.95 | +74.88% |
| December, 2024 | $13.24 | $11.61 | $31.27 | +99.47% |
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2025
Relay Therapeutics Inc Stock (RLAY) is expected to reach an average price of $7.0999 in 2025, with a high prediction of $14.17 and a low estimate of $0.0344. This indicates an +6.93% rise from the last recorded price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.3285 | $1.307 | $14.17 | -19.75% |
| February, 2025 | $2.2215 | $0.38 | $7.8692 | -66.54% |
| March, 2025 | $1.3455 | $0.132 | $4.4437 | -79.74% |
| April, 2025 | $4.0782 | $0.4633 | $5.1482 | -38.58% |
| May, 2025 | $8.0912 | $2.849 | $9.0262 | +21.86% |
| June, 2025 | $3.4242 | $1.9427 | $8.4619 | -48.43% |
| July, 2025 | $3.7179 | $1.0572 | $5.7664 | -44.01% |
| August, 2025 | $8.9909 | $2.9787 | $9.7109 | +35.41% |
| September, 2025 | $6.9539 | $1.0224 | $10.54 | +4.73% |
| October, 2025 | $8.0077 | $1.9754 | $10.76 | +20.60% |
| November, 2025 | $2.3007 | $1.2107 | $9.4184 | -65.35% |
| December, 2025 | $1.0744 | $0.0344 | $8.0779 | -83.82% |
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2026
The predicted value for Relay Therapeutics Inc (RLAY) in 2026 is set at an average of $6.7461. Estimates vary from a peak of $13.47 to a trough of $0.0179, indicating an +1.60% surge from the present price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8326 | $3.0498 | $2.5333 | -42.28% |
| February, 2026 | $0.0204 | $1.7196 | $2.7211 | -99.69% |
| March, 2026 | $5.1834 | $1.3473 | $6.5734 | -21.94% |
| April, 2026 | $5.0772 | $4.5572 | $12.26 | -23.54% |
| May, 2026 | $4.9198 | $0.0179 | $7.1079 | -25.91% |
| June, 2026 | $7.6969 | $6.0034 | $4.2484 | +15.92% |
| July, 2026 | $1.3169 | $3.6231 | $4.7661 | -80.17% |
| August, 2026 | $0.7001 | $1.6209 | $3.0984 | -89.46% |
| September, 2026 | $5.3036 | $0.8279 | $6.9936 | -20.13% |
| October, 2026 | $3.2066 | $2.0709 | $13.47 | -51.71% |
| November, 2026 | $3.8996 | $0.5189 | $5.1474 | -41.27% |
| December, 2026 | $0.7234 | $0.2134 | $4.7211 | -89.11% |
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Relay Therapeutics Inc (RLAY) is $3.4882, with a high forecast of $6.9724 and a low forecast of $0.00412. This indicates an -47.47% decrease from the last price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2836 | $0.00412 | $1.4756 | -95.73% |
| February, 2027 | $3.9994 | $1.6906 | $5.1194 | -39.77% |
| March, 2027 | $3.4931 | $2.8601 | $6.9724 | -47.39% |
| April, 2027 | $1.6261 | $0.3061 | $3.7546 | -75.51% |
| May, 2027 | $1.5291 | $0.1224 | $3.4069 | -76.97% |
| June, 2027 | $2.9672 | $1.1906 | $4.5706 | -55.31% |
| July, 2027 | $2.5342 | $3.1542 | $3.1607 | -61.83% |
| August, 2027 | $1.2412 | $1.5912 | $1.9634 | -81.31% |
| September, 2027 | $0.1824 | $0.5782 | $0.7518 | -97.25% |
| October, 2027 | $1.2544 | $0.0967 | $0.6144 | -81.11% |
| November, 2027 | $1.5514 | $1.0922 | $0.7729 | -76.64% |
| December, 2027 | $2.8377 | $1.9607 | $2.0592 | -57.26% |
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2028
In 2028, Relay Therapeutics Inc (RLAY) is projected to reach an average price of $18.79, with a high projection of $37.48 and a low estimate of $0.0994. This indicates an +182.99% rise from the last price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.4947 | $3.5347 | $3.5054 | -62.43% |
| February, 2028 | $1.5417 | $1.7324 | $1.5739 | -76.78% |
| March, 2028 | $2.2621 | $0.0994 | $2.9721 | -65.93% |
| April, 2028 | $1.5351 | $1.4451 | $3.6736 | -76.88% |
| May, 2028 | $2.5188 | $0.7873 | $3.5888 | -62.07% |
| June, 2028 | $1.0318 | $0.9618 | $3.5918 | -84.46% |
| July, 2028 | $0.6748 | $0.254 | $1.804 | -89.84% |
| August, 2028 | $30.66 | $0.2945 | $30.56 | +361.75% |
| September, 2028 | $40.69 | $39.05 | $37.48 | +512.86% |
| October, 2028 | $37.06 | $33.88 | $33.26 | +458.10% |
| November, 2028 | $29.91 | $31.05 | $33.50 | +350.46% |
| December, 2028 | $32.91 | $29.38 | $30.14 | +395.70% |
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2029
The 2029 price forecast for Relay Therapeutics Inc Stock (RLAY) is $24.44 on average, with a high prediction of $31.93 and a low estimate of $16.95. This represents an +268.04% increase from the previous price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.61 | $17.01 | $25.27 | +135.05% |
| February, 2029 | $20.45 | $16.95 | $17.71 | +208.00% |
| March, 2029 | $4.6651 | $21.49 | $23.52 | -29.74% |
| April, 2029 | $21.46 | $18.11 | $18.37 | +223.18% |
| May, 2029 | $29.41 | $24.91 | $24.08 | +342.95% |
| June, 2029 | $29.96 | $28.35 | $27.07 | +351.14% |
| July, 2029 | $32.22 | $31.26 | $31.93 | +385.23% |
| August, 2029 | $24.66 | $27.15 | $29.76 | +271.42% |
| September, 2029 | $23.90 | $22.52 | $23.37 | +259.88% |
| October, 2029 | $24.44 | $26.25 | $24.45 | +268.05% |
| November, 2029 | $24.84 | $25.19 | $24.55 | +274.14% |
| December, 2029 | $23.69 | $19.79 | $21.93 | +256.73% |
Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2030
Relay Therapeutics Inc Stock (RLAY) is expected to reach an average price of $21.69 in 2030, with a high forecast of $27.33 and a low forecast of $16.06. This signifies an +226.70% surge from the last price of $6.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.48 | $23.59 | $23.49 | +208.42% |
| February, 2030 | $22.87 | $18.91 | $16.92 | +244.48% |
| March, 2030 | $22.35 | $24.30 | $21.59 | +236.55% |
| April, 2030 | $24.14 | $21.28 | $22.20 | +263.57% |
| May, 2030 | $28.42 | $28.12 | $27.33 | +328.07% |
| June, 2030 | $27.52 | $25.81 | $27.09 | +314.42% |
| July, 2030 | $14.86 | $16.70 | $21.83 | +123.80% |
| August, 2030 | $21.53 | $16.06 | $15.57 | +224.31% |
| September, 2030 | $26.91 | $25.16 | $26.13 | +305.24% |
| October, 2030 | $21.96 | $26.96 | $26.32 | +230.73% |
| November, 2030 | $22.30 | $23.53 | $24.11 | +235.91% |
| December, 2030 | $19.88 | $22.19 | $20.53 | +199.38% |
0.77%
1.20%
Cap:
|
Volume (24h):